RACTHERA Inc. Corporate Website Launch Announcement

RACTHERA Inc. has launched its corporate website.

We are a joint venture established through joint investment by Sumitomo Chemical and Sumitomo Pharma, serving as the core of the Sumitomo Chemical Group’s regenerative and cell therapy business. We are advancing research and development of regenerative medicine products, primarily those derived from iPS cells, aiming to create innovative treatments for diseases that have been difficult to treat and deliver them to patients worldwide as soon as possible.

This website will provide a wide range of information, including our business strategy, R&D pipeline, latest announcements, disclosure of publicly funded research information, and our compliance initiatives.

We look forward to your continued support of RACTHERA Co., Ltd.